Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Cash from Financing Activities (2016 - 2017)

Historic Cash from Financing Activities for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $1.4 million.

  • Bone Biologics' Cash from Financing Activities changed N/A to $1.4 million in Q3 2017 from the same period last year, while for Dec 2017 it was $3.4 million, marking a year-over-year decrease of 5024.23%. This contributed to the annual value of $7.9 million for FY2021, which is 186231.04% up from last year.
  • Latest data reveals that Bone Biologics reported Cash from Financing Activities of $1.4 million as of Q3 2017.
  • Over the past 5 years, Bone Biologics' Cash from Financing Activities peaked at $5.6 million during Q1 2016, and registered a low of $1.2 million during Q4 2016.